Ewing Sarcoma (MSK, Cancer Research 2024)

Summary

Ewing Sarcoma (MSK, Cancer Research 2024) is a study catalogued by cBioPortal DataHub under the cancer-type code es. EvidenceHelix groups it with sarcoma and soft tissue studies.

Study description

Targeted Sequencing of 277 Ewing sarcoma and Desmoplastic small round cell patient tumors with their matched normal pairs via MSK-IMPACT platform to detect EWSR1 chromoplexy-associated structural rearrangements.

Text as published in the source's study metadata.

Citation & PubMed

Josephine K et al. Cancer Research 2024

Linked PubMed records: PMID 38335254

Source & licence

Metadata from cBioPortal DataHub at e1b75cd25b, available under the ODC Open Database License (ODbL) 1.0. See the Source metadata tab for every field.

Source metadata

Study identifier

es_dsrct_msk_2023

Short name

not given

Source cancer-type code

es

Reference genome

hg19

Source access groups

PUBLIC

Original study

View on cBioPortal

Metadata file

meta_study.txt at e1b75cd25b

Database licence

ODC Open Database License (ODbL) 1.0

Study-level metadata only (title, description, cancer-type code, citation, PubMed ids). No patient, sample, mutation or clinical data, and no publication full text, is included. Individual studies may carry their own terms; follow each study's source links before reusing its data.

Citations

Josephine K et al. Cancer Research 2024

• PubMed record 38335254 ↗

Citation counts are not part of the source metadata and are not shown.

Related studies

• Ewing Sarcoma (Institut Curie, Cancer Discov 2014)

  Whole-genome sequencing of 112 Ewing sarcoma samples and matched germ line DNA.

  Sarcoma and soft tissueOther published and consortium studiesSource code esPubMed 1

• Pediatric Ewing Sarcoma (DFCI, Cancer Discov 2014)

  Whole exome sequencing of 96 pediatric Ewing Sarcoma tumors and 11 cell lines.

  Sarcoma and soft tissueOther published and consortium studiesSource code esPubMed 1

• Gastrointestinal Stromal Tumor (MSK, NPJ Precis Oncol 2023)

  Paired analysis of 499 Gastrointestinal stromal tumor/normal pairs via MSK-IMPACT platform.

  Sarcoma and soft tissueMSK studiesSource code gistPubMed 1

• Gastrointestinal Stromal Tumors (MSK, Clin Cancer Res 2023)

  Targeted sequencing of 469 gastrointestinal stromal tumors and their matched normals via MSK-IMPACT.

  Sarcoma and soft tissueMSK studiesSource code gistPubMed 1

• Pediatric Rhabdomyosarcomas (MSK, JCO Precis Oncol 2023)

  Targeted sequencing of 24 cases with extremity rhabdomyosarcoma tumors and their matched normals (MSK Cohort) via MSK-IMPACT.

  Sarcoma and soft tissueMSK studiesSource code rmsPubMed 1

• Rhabdomyosarcomas (MSK, NPJ Precis Oncol 2023)

  Sequential targeted sequencing on 20 rhabdomyosarcoma tumors and their matched normals from the MSK cohort using MSK-IMPACT.

  Sarcoma and soft tissueMSK studiesSource code rmsPubMed 1

• Sarcoma (MSK, J Pathol 2023)

  Targeted sequencing of 82 radiation-associated sarcomas and their matched normals via MSK-IMPACT.

  Sarcoma and soft tissueMSK studiesSource code mixedPubMed 1

• Sarcoma (MSK, Nat Commun. 2022)

  Targeted Sequencing of 2138 Sarcoma samples and matched normals via MSK-IMPACT.

  Sarcoma and soft tissueMSK studiesSource code soft_tissuePubMed 1

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.